Glioblastoma heterogeneity and the tumour microenvironment: implications for preclinical research and development of new treatments

preclinical studies using brain organoid models to better model glioblastoma and its interactions with the surrounding healthy brain tissue, which may play an essential role in developing new and more personalised treatments for this aggressive type of cancer.